1. 2022-RA-708-ESGO Real-world assessment of patients with ovarian cancer who received niraparib as second-line maintenance therapy in the United States: did first-line maintenance approval change the patient profile for second-line maintenance therapy?. (20th October 2022) Authors: Backes, Floor; Calderón Boyle, Tirza Areli; Perhanidis, Jessica; Lim, Jonathan; Kalilani, Linda; Hurteau, Jean A; Golembesky, Amanda; Salani, Ritu Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-949-ESGO VOCAL (views of ovarian cancer patients-how maintenance therapy affects their lives) study: patient preference for treatment formulation and administration. (20th October 2022) Authors: Wethington, Stephanie; Shukla, Soham; de Courcy, Joanna; Ellis, Hilary; Hanlon, Jennifer; Golembesky, Amanda; Taylor-Whiteley, Teresa; Chase, Dana M Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA. (19th March 2019) Authors: Lim, Jonathan; Samuelsen, Carl; Golembesky, Amanda; Shrestha, Sulena; Wang, Li; Griebsch, Ingolf Journal: Future oncology Issue: Volume 15:Number 13(2019) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States. (2nd January 2020) Authors: Samuelsen, Carl; Lim, Jonathan; Golembesky, Amanda; Shrestha, Sulena; Wang, Li; Griebsch, Ingolf Journal: Journal of medical economics Issue: Volume 23:Number 1(2020) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-104 SECURE: An Observational Study of Certolizumab Pegol in Crohn's Disease—Events of Interest Analysis with 5869 Patient-Years at Risk. (March 2016) Authors: Lee, Scott; Wolf, Doug; Feagan, Brian; Lichtenstein, Gary; Andrews, Elizabeth; Stidham, Ryan; Aberra, Faten; Aguilar, Humberto; Kayhan, Cem; Kosutic, Gordana; Sen, David; Golembesky, Amanda; Hasan, Iram; Spearman, Marshall; Loftus, Edward Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-104 SECURE: An Observational Study of Certolizumab Pegol in Crohn's Disease—Events of Interest Analysis with 5869 Patient-Years at Risk. (March 2016) Authors: Lee, Scott; Wolf, Doug; Feagan, Brian; Lichtenstein, Gary; Andrews, Elizabeth; Stidham, Ryan; Aberra, Faten; Aguilar, Humberto; Kayhan, Cem; Kosutic, Gordana; Sen, David; Golembesky, Amanda; Hasan, Iram; Spearman, Marshall; Loftus, Edward Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S0849 Characteristics of Patients With Crohn's Disease by History of Perianal Fistula Who Enrolled in the Corrona® Inflammatory Bowel Disease Registry. (October 2020) Authors: Fan, Yanni; Golembesky, Amanda; Moore, Page C.; Crabtree, Margaux; Mackey, Rachel H.; Aros, Silvia Delgado; Valdecantos, Wendell; Stidham, Ryan W. Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety of cetirizine in pregnancy. (3rd October 2018) Authors: Golembesky, Amanda; Cooney, Maureen; Boev, Rossen; Schlit, Anne-Françoise; Bentz, Jürgen W. G. Journal: Journal of obstetrics and gynaecology Issue: Volume 38:Number 7(2018) Page Start: 940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study. (19th October 2018) Authors: Hochmair, Maximilian J; Morabito, Alessandro; Hao, Desiree; Yang, Cheng-Ta; Soo, Ross A; Yang, James C-H; Gucalp, Rasim; Halmos, Balazs; Wang, Lara; Golembesky, Amanda; Märten, Angela; Cufer, Tanja Journal: Future oncology Issue: Volume 14:Number 27(2018) Page Start: 2861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. VOCAL (Views of Ovarian Cancer patients-how maintenance therapy Affects their Lives) study: A lens into the financial and quality of life (QoL) impact of disease burden and ethnic disparities reported directly by the patient. Issue 28 (1st October 2022) Authors: Chase, Dana Meredith; Shukla, Soham; de Courcy, Joanna; Ellis, Hilary; Piercy, James; Taylor-Whiteley, Teresa; Golembesky, Amanda; Wethington, Stephanie L. Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗